{"name":"BlackThorn Therapeutics, Inc.","slug":"blackthorn-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BTRX-246040","genericName":"BTRX-246040","slug":"btrx-246040","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"BTRX-246040","genericName":"BTRX-246040","slug":"btrx-246040","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPR2JfMlo2LUthMFFESW0zOE5LWERZUTZqNmpJd2prcm9rV0FYVEliWjVXY1ZLUXhZTTg5RmF0SmxWbXVhSTgtbTRFY2VQLThsS3ltZ3pyenl0T3pJaGhma1ZoWGRFaUVYZDRnYjNqTzhyWnlKWDExY0puM2JMemdOdmUzdDBaVzlzQ1B0ZDhVNTVBcEJsM2JEYktSR2EwbVZVSVdTMExIdFF2QzlkSlRVX0gtRE9MNFdBT1diNWhKd3A3blpUOHpISnFWYldjckE5T2NQcXlDSkNIc2NjNlhnWm9Kd0ZVck4tanZQZVNPRXFJZDU0a3VHN1gzVlVnLVc4Q1YzRzVNb3g?oc=5","date":"2025-09-11","type":"pipeline","source":"GlobeNewswire","summary":"Bipolar Disorder Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight - GlobeNewswire","headline":"Bipolar Disorder Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNbXJCR1JkV3UtX0RrVHdmTkVnMjV4ajkxV21GZVBGczN4X0dHeVhlZW1Yby1Dby1uSnB1SW92Vmk0ZjkxeTVUUWpUQkpXc2JwU0tfbzJLS3VLc0VCTlY0RzVrOUoyVGpjcG5WU3QzN2laOHlzTGNiU09rVFhtZXU1OVp2WGxWOXpkTjItbDZKYmZFZw?oc=5","date":"2023-07-18","type":"pipeline","source":"BioPharma Dive","summary":"An Arch-backed biotech pushes its depression drug into late-stage testing - BioPharma Dive","headline":"An Arch-backed biotech pushes its depression drug into late-stage testing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNalJZYUl2SVFWVko1Q2hfN0R5cEt5RVFzTE9DWUFfLVQzemdIRVlNSFRKbnB5cUtsWThYN2NSbFFaSGlEbXdnRnRFTmtHS0g3OWtHQ0V3VEVxMkxzRnFWa1lSbW9FNzJMQ3Q5aGEwb3U2dEhUYkxGdXhvajNUSG8tSTI3Yw?oc=5","date":"2022-07-06","type":"pipeline","source":"Psychiatrist.com","summary":"Association of Symptoms of Posttraumatic Stress Disorder and GrimAge, an Epigenetic Marker of Mortality Risk, in US Military Veterans - Psychiatrist.com","headline":"Association of Symptoms of Posttraumatic Stress Disorder and GrimAge, an Epigenetic Marker of Mortality Risk, in US Mili","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNQ1ZqcEZGZVo5dThYcTBsV29MTV8tQ1ZkWjNweUE2bjl5S25NUllFZFdRazFvMFF4cm1yV2x0Tml6RXJEdHJmdUtPZ0kwcmR2YzBfWEdCLVBNVVhSS1hLX3Q2dGNaRXhqU3lDNktrQnlrWml3d0dYUUstakxteXc1TjVGN3U0ZFVtbnVsRmp4SnN3NmxqYWVySU1yVnNIbUpjOEtZRDFRTHpKNUxFOVJzaWxfc19RRndPY2l4TDZUTWM5eUZaYTZCM0pLTm0?oc=5","date":"2022-02-10","type":"pipeline","source":"BioSpace","summary":"Elios Therapeutics Announces the Appointment of Mark H.N. Corrigan, M.D. as Chairman of the Board of Directors - BioSpace","headline":"Elios Therapeutics Announces the Appointment of Mark H.N. Corrigan, M.D. as Chairman of the Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOb3BmUGtZM3o0aFEtMk13RGJNSU1zN296RUdvcW1jbDg4VFE5b041cGN1R2wxMUNhLXQ4dkE0WXpfMXdWLWNGdDJTYTNWU2N3LVd0R2loQ3pmZ3dLdUc4S0VwUmpzaGFuRnhIRHFlSlQ2alJxNmhuLURFZlZVSWFCZDFsemU1Qkd6ZGhucVhWYzMxMkF6Yy1iXzZ5bG02aURT?oc=5","date":"2021-12-01","type":"pipeline","source":"Pharmaceutical Online","summary":"Using AI In Drug Discovery: The Latest Market Research - Pharmaceutical Online","headline":"Using AI In Drug Discovery: The Latest Market Research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOem44YVFMR2VBOEZiUVZmOVk1cEFVX2wzcUZ5NUVqUWYwVDRiOVg3aGFNeERQaGtLc0lKRS1jUVhZd1BDNEtaUkszV3l4M1BCWi1UX3lOZTNFcTZ6QTVYeGdDc3pEVzFLaEdmYWdldGY4bmlsQ09YT2ZCRzJpX0F4TG4xUmVQOWhYQlZrRGN4WWJ4WjFic0JGcGxqMEJ6UVQxd3dnVUNheE90WnZkRXBlcnh3b0pxS2N2TndnbjR2UTlHRVk?oc=5","date":"2021-10-26","type":"pipeline","source":"citybiz","summary":"Exo Therapeutics Appoints Dorothy Lou Bailey as SVP, Corporate Development and Strategy - citybiz","headline":"Exo Therapeutics Appoints Dorothy Lou Bailey as SVP, Corporate Development and Strategy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQQlZ3ZHVVY3BTZVpNUFEwZEdmQ0VRU3p5TXFSdjZYbUFSZHM0bTV1eUlVcWFaT3ljbDZoeVBNcGdUQllYUmdCTGlHeWpOUTdUdEZZMFo3YlFYc2JLSkp6N2JwcEVrVmF2V2ZzZE51N185YVdJd2FOMEtxclFnOVpaTGtiRkd6a2k2eEZmTA?oc=5","date":"2021-10-07","type":"pipeline","source":"BioPharma Dive","summary":"Armed with half a billion dollars, a startup aims to change how brain drugs are made - BioPharma Dive","headline":"Armed with half a billion dollars, a startup aims to change how brain drugs are made","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPNjJHelBDM2p1UURWeXNHZXIzMnRCTGZHVDE3d1hRR3FucVpLaW40VFd3QlBVbWFuakN0S1Y4eEpZWTVUVnBvTEpCaEhyc2FmYWNfTU9OV09jeUVvdjgwRnBYQUc0YVBZd2RaY0ZTd09OUjBqNUM3ak40VnU2UDZNd2wxdXFEM182RVJTdmwxTnNYNnpLUGVEMktILU96NHFRa3BfZzBhbFZuVkJBcXpZUFl1cHF6ZDBZNGJBSA?oc=5","date":"2021-10-07","type":"deal","source":"Fierce Biotech","summary":"Meet Neumora, Arch's $500M, Amgen-partnered play for the targeted future of neuroscience R&D - Fierce Biotech","headline":"Meet Neumora, Arch's $500M, Amgen-partnered play for the targeted future of neuroscience R&D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxONDVVZjl0OGgwZ3B4UW5SM1RaS25XUHZxbXZMLUxXaHpxSE9yWTA0UWUxbmxxdXROcFAzQjIxQS1FNDZXV1J3eDMzVUluUnlSdW5ybUtxNXdlb3o4ZEZCVDRyY3FRZ1lIMHlUNDRJYWVaNC1JZHl3VHNDRW5IM3BrbFo5eENkdWNOOHdHNjMxczRFSUk1SFcyUF93Mm5fTFctWVZjRE5FVmNqMXM?oc=5","date":"2019-01-08","type":"pipeline","source":"The Business Journals","summary":"At biotech's big event, a chance to shape LGBTQ diversity on boards - The Business Journals","headline":"At biotech's big event, a chance to shape LGBTQ diversity on boards","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}